MIRA INFORM REPORT

 

 

Report Date :

09.06.2012

 

IDENTIFICATION DETAILS

 

Name :

EL OS FORMUSOLS INDIA PRIVATE LIMITED

 

 

Registered Office :

4 and 5, Subbu Plaza, 2nd Floor, 85-A, State Bank Road, Coimbatore – 641018, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

12.07.2000

 

 

Com. Reg. No.:

18-009420

 

 

Capital Investment / Paid-up Capital :

Rs.5.000 Millions

 

 

CIN No.:

[Company Identification No.]

U72200TZ2000PTC009420

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Developers and Manufacturers of Solutions for Dialysis and Other Usage.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (30)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 30100

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. Profitability of the company appears to be low. However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for small business dealings at usual trade terms and conditions.

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

 

 

 

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

LOCATIONS

 

Registered Office :

4 and 5, Subbu Plaza, 2nd Floor, 85-A, State Bank Road, Coimbatore – 641018, Tamilnadu, India

Tel. No.:

91-422-2393618

Fax No.:

Not Available

E-Mail :

kaleemandco@gmail.com

Website :

http://www.el-os.com

 

 

Head Office :

#85, Tank Road, Chinnavedapatty, Coimbatore – 641006, Tamilnadu, India

Tel. No.:

91-422-6580887

Fax No.:

91-422-2306161

E-Mail :

elos@sify.com

info@el-os.com

marketing@el-os.com

 

 

Branch Office :

No.36, Iyyanar Kovli, 2nd Street, K. K. Ngar, Madurai – 625020, Tamilnadu, India 

Tel No.:

91-452-6503360

Email :

madurai@el-os.com

 

 

DIRECTORS

 

(AS ON 15.09.2011)

 

Name :

Mr. Santhanam Jagan

Designation :

Director

Address :

77-M, Surya Apartments, srinivasan Ragavan Street, R. S. Puram, Coimbatore – 641002, Tamilnadu, India

Date of Birth/Age :

07.12.1971

Date of Appointment :

12.07.2000

DIN No.:

00020990

 

 

Name :

Mr. Venkaatesan Balan

Designation :

Director

Address :

No.1, Warners Road, Contonment, Tiruchi – 620001, Tamilnadu, India

Date of Birth/Age :

06.02.1969

Date of Appointment :

12.07.2000

DIN No.:

00022711

 

 

Name :

Mr. Krishnan Anand

Designation :

Director

Address :

No.23, Mullai Nagar, Coimbatore – 641041, Tamilnadu, India

Date of Birth/Age :

17.08.1973

Date of Appointment :

12.07.2000

DIN No.:

00022763

 

 

Name :

Mr. Ashok Parasuraman

Designation :

Director

Address :

No.70, SRP Nagar No.1, Alagesan Road No. II, Post, Coimbatore – 641011, Tamilnadu, India

Date of Birth/Age :

26.04.1954

Date of Appointment :

03.06.2009

DIN No.:

01968517

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 15.09.2011)

 

Names of Shareholders

 

 

No. of Shares

 

 

 

Jagan Santhanam

 

90000

Krishnan Anand

 

80000

Venkaatesan Balan

 

82000

Ranjani Ashok

 

91000

Vidhya Bathrinarayan

 

71000

S, Srikanth

 

86000

 

 

 

Total

 

 

500000

 

 

(AS ON 30.09.2011)

Equity Shares Break – up

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Developers and Manufacturers of Solutions for Dialysis and Other Usage.

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

A] As no Industrial License is required, Licensed Capacity cannot be mentioned.

 

B) Installed Capacity 24.00 lac ltrs / annum.

 

C) Actual Production:

 

Particulars

Ltrs/ Kgs

2010-2011

 

 

Concentrated Acetate Solution

29720.00 Ltrs

Concentrated Bicarbonate Solution

1773520.00Ltrs

Dextrose Monohydrate Powder

10692.00 Kgs

Sodium Bicarbonate Powder

2107993.35Kgs

Sodium Chloride Powder

71443.00 Kgs

Cleaning Fluid

3080.00 Ltrs

 

 

GENERAL INFORMATION

 

Suppliers :

·         Advanced Life Sciences Private Limited

·         Asia Crystal Chemicals Private Limited

·         B Braun Medical (India) Private Limited

·         B. L. Lifesciences Private Limited

·         Deluxe Packaging

·         Gemm Chemical

·         Gokul Water Supply

·         J.N. Freight Forwarders Private Limited

·         Kirloskar Technologies (Private) Limited

·         Ksk Diagnostics Private Limited

·         KPC Filtech Private Limited

·         Medi Focus India Private Limited

·         R.N. Poly Container Private Limited

·         Roche Diagnostics India Private Limited

·         Sandor Medicaids Private Limited

·         Sathyam Trading Corporation

·         The Precision Scientific Company

·         Thudiyalur Medical Stores

·         Vadamalayan Hospital

 

 

Customers :

·         Anbu Hospital Multi Speciality

·         Apex Agencies

·         Apollo Logo Hospital

·         Babu Dialysis Centre

·         B| Braun Medical India Private Limited

·         Carris Pipes And Tubes (Private) Limited

·         Coimbatore Kidney Care and Research Centre

·         Fisher and Paykel Healthcare India Private Limited

·         G. Kuppusamy Naidu Memorial Hospital

·         Gem Hospital Private Limited

·         Hindu Mission Health Services

·         Hll Lifecare Limited

·         Kalki Medical Enterprises

·         Medi Tech Corporations

·         Pariyaram Medical College and Hospital

·         Progressive Health Care

·         Rmi Win Medical Agencies

·         Sri Abirami Hospital Private Limited

·         Sri Kumaran Hospital

·         Sri Chakra Multi Speciality Hospital

·         Supreme Health Care (Bangalore) Private Limited

·         Vasantham Health Centre (Private) Limited

·         Vedanayagam Hospital (Private) Limited

·         Vinayaka Research Foundation

·         Wewin Enterprises

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         State Bank of Travancore

P. N. Palayam Branch, 725-B, Avinashi Road, Coimbatore – 641018, Tamilnadu, India 

 

·         Kotak Mahindra Bank

·         Oriental Bank of Commerce

·         ICICI Bank

·         State Bank of India

 

 

Facilities :

Secured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

 

Kotak Mahindra Bank- EICHER Loan

0.000

0.214

Oriental Bank of Commerce - Term Loan

6.348

0.000

Oriental Bank of Commerce - CC Account

20.654

3.122

Sundaram Finance Limited - Term Loan

0.692

0.000

 

 

 

Total

 

27.694

3.336

 

 

Unsecured Loans

31.03.2011

31.03.2010

 

 

(Rs. In Millions)

 

 

 

Loan from Directors and Relatives

5.273

6.735

 

 

 

Total

 

 

5.273

6.735

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Kaleem and Company

Chartered Accountant

Address :

II Floor, 434, Oppanakara Street, Coimbatore – 641001, Tamilnadu, India 

PAN No.:

AAJFK3383K

 

 

CAPITAL STRUCTURE

 

(AS ON 15.09.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.10/- each

Rs.5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

500000

Equity Shares

Rs.10/- each

Rs.5.000 Millions

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

5.000

0.600

0.600

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

2.525

1.212

0.770

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

7.525

1.812

1.370

LOAN FUNDS

 

 

 

1] Secured Loans

27.694

3.336

0.460

2] Unsecured Loans

5.273

6.735

3.970

TOTAL BORROWING

32.967

10.071

4.430

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

40.492

11.883

5.800

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

7.449

1.824

1.676

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

3.005

0.000

0.000

DEFERREX TAX ASSETS

0.158

0.063

0.070

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

17.192

5.385

0.234

 

Sundry Debtors

19.909

4.675

2.376

 

Cash & Bank Balances

3.013

0.599

0.107

 

Other Current Assets

1.627

0.528

0.327

 

Loans & Advances

5.352

7.871

5.146

Total Current Assets

47.093

19.058

8.190

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

14.712

4.945

0.642

 

Other Current Liabilities

1.114

3.503

2.668

 

Provisions

1.387

0.614

0.826

Total Current Liabilities

17.213

9.062

4.136

Net Current Assets

29.880

9.996

4.054

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

40.492

11.883

5.800

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

TOTAL                                     (A)

97.975

26.938

11.996

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                     (B)

93.607

25.638

10.732

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

4.368

1.300

1.264

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

2.101

0.209

0.186

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

2.267

1.091

1.078

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.766

0.480

0.472

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

1.501

0.611

0.606

 

 

 

 

 

Less

TAX                                                                  (H)

0.187

0.200

0.170

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

1.314

0.411

0.436

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Dialog+ Dialysis Machines and Medical Disposables (Trading)

17.491

4.977

Nil

 

TOTAL IMPORTS

17.491

4.977

Nil

 

 

 

 

 

 

Earnings Per Share (Rs.)

2.62

6.85

7.27

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

1.34

1.53

3.63

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.75

2.93

6.14

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.20

0.34

0.44

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

6.67

10.56

6.25

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.74

2.10

1.98

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Check list by info Agents

Available in Report

(Yes/ No)

 

 

Year of Establishment

Yes

Locality of the Firm

Yes

Constitution of the Firm

Yes

Premises details

No

Type of Business

Yes

Line of Business 

Yes

Promoter’s Background 

No

No. of Employees

Yes

Name of Person Contacted

No

Designation of Contact person

No

Turnover of Firm for last three years

Yes

Profitability for last three years

Yes

Reasons for variation <> 20%

-----

Estimation for coming financial year

No

Capital in the business

Yes

Details of sister concerns

No

Major Suppliers

Yes

Major Customers

Yes

Payments Terms

No

Export/ Imports Details (If applicable)

No

Market Information

-----

Litigations that the firm/ Promoters Involved in

-----

Banking details

Yes

Banking Facility Details

Yes

Conduct of the Banking Account

-----

Buyer visit details

-----

Financials, if provided

Yes

Incorporation details is applicable

Yes

Last Accounts filed at ROC

Yes

Major Shareholders, if available

Yes

 

 

NOTE:

 

The Registered office of the company has been shifted from, 77-H, Surya Apartment, S Srinivasa Ragavan Street, R S Puram, Coimbatore – 641002, Tamilnadu, India, to the present address w.e.f. 23.07.2010.

 

 

REVIEW OF OPERATION

 

The company manufactures dialysis fluids and imports dialysis disposables, for resale.

 

The Directors proudly states that with the award of Distributorship for the states of Tamilnadu and Kerala by M/s. B|Braun Medical SDN BHD Germany, the company performed far and above the expected levels. Appreciating the super performance by the company M/s. B|Braun Medical SDN BHD Germany have awarded them the franchisee for selling trading of sparse, service and installation of their Dialog + Dialysis machines in the states of Tamilnadu and kerala. With the absorption of the firms M/s. Heartassist and M/s. Lifemedsystem the company could perform far better and has multiplied the sales Turnover. The Company has been very highly successful in all the fronts it has taken up business and it is expected that the turnover would more than double in the ensuing financial year. The company has standardized all its functions and operations and has been awarded ISO 9001: 2008 quality management certification by Bureau of Assessment services.

 

 

FIXED ASSETS:

 

·         Air Conditioner

·         Computer

·         Electrical Equipment

·         Fax

·         Fax Machine

·         Furniture and Fixture

·         Land

·         Mobile Phone

·         Plant and Machinery

·         Printer

 

 

WEBSITE DETAILS:

 

PROFILE:

 

Company started in the year 2000, situated in a place called Coimbatore the Manchester of South India, one of the fastest growing cities in southern India situated in Tamilnadu; they also have an easy accessibility to all the southern states of India. Having been in the market for a decade, they now hold a market share of around 40-50 % due to the quality, standards and produce which they have done for the last couple of years. They wish to uphold and expand in a big way in the days to come with the support of all their customers. The primary objective is to produce not quantity but the quality of Haemodialysis fluid that could make a difference to mankind.


The company is well equipped and furnished within an area of around 3000sq.ft built to the standard requirements and specifications of Schedule “M” - GMP of the Pharmaceutical act which is the basic standards for this industry.


The in house laboratory which is fully equipped with latest equipments confirms the quality of the product produced.

The Microbiological Laboratory support the Industrial Hygienists for Microbiological Contaminants.


RESEARCH AND DEVELOPMENT (R&D)


The Research and Development wing is in the Development of Powder form of Dialysate for easy Transportation and to Save Storage Space. Patient Friendly and User Friendly devices are their keen departments.

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.36

UK Pound

1

Rs.85.64

Euro

1

Rs.69.21

 

 

INFORMATION DETAILS

 

Report Prepared by :

NIT

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

30

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.